AstraZeneca has been pulling out all the stops in trying to preserve blockbuster Nexium's revenues for as long as it can. Now, the FDA has approved an over-the-counter version of the drug–but thanks to a 2012 agreement, those sales are on their way to Pfizer.
written on 31.03.2014